1. Home
  2. INTS vs AMST Comparison

INTS vs AMST Comparison

Compare INTS & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • AMST
  • Stock Information
  • Founded
  • INTS 2012
  • AMST 2017
  • Country
  • INTS United States
  • AMST United States
  • Employees
  • INTS N/A
  • AMST N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • AMST Computer Software: Prepackaged Software
  • Sector
  • INTS Health Care
  • AMST Technology
  • Exchange
  • INTS Nasdaq
  • AMST Nasdaq
  • Market Cap
  • INTS 9.4M
  • AMST 9.5M
  • IPO Year
  • INTS 2023
  • AMST 2020
  • Fundamental
  • Price
  • INTS $0.32
  • AMST $2.65
  • Analyst Decision
  • INTS Strong Buy
  • AMST
  • Analyst Count
  • INTS 3
  • AMST 0
  • Target Price
  • INTS $8.50
  • AMST N/A
  • AVG Volume (30 Days)
  • INTS 2.7M
  • AMST 41.9K
  • Earning Date
  • INTS 08-07-2025
  • AMST 05-15-2025
  • Dividend Yield
  • INTS N/A
  • AMST N/A
  • EPS Growth
  • INTS N/A
  • AMST N/A
  • EPS
  • INTS N/A
  • AMST N/A
  • Revenue
  • INTS N/A
  • AMST $82,544.00
  • Revenue This Year
  • INTS N/A
  • AMST N/A
  • Revenue Next Year
  • INTS N/A
  • AMST N/A
  • P/E Ratio
  • INTS N/A
  • AMST N/A
  • Revenue Growth
  • INTS N/A
  • AMST N/A
  • 52 Week Low
  • INTS $0.26
  • AMST $2.00
  • 52 Week High
  • INTS $5.10
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • INTS 37.08
  • AMST 45.78
  • Support Level
  • INTS $0.28
  • AMST $2.67
  • Resistance Level
  • INTS $0.32
  • AMST $2.72
  • Average True Range (ATR)
  • INTS 0.06
  • AMST 0.15
  • MACD
  • INTS 0.01
  • AMST -0.05
  • Stochastic Oscillator
  • INTS 7.43
  • AMST 26.89

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: